On September 21st 2017, Sebastian Botzenhardt, researcher involved in DEEP project (DEEP PhD), held the final examination for his doctoral thesis at Friedrich-Alexander-University Erlangen-Nuremberg, where he exposed the overall results of a study aimed to assess the drug safety profile of oral chelator deferiprone (DFP […]
The DEEP project has received research funding from the European Union under the 7th Framework Programme
News | DEEP Project - Part 2
DEEP-3 study results published in the January issue of Haematologica
Sebastian Botzenhardt from University Hospital of Erlangen and his co-writers have just published the results of the DEEP-3 study in the January issue of Haematologica on behalf of the DEEP consortium.
DEEP (Deferiprone Evaluation in Paediatrics) is funded EU-funded project aimed to investigate safety and […]
The pilot study QuBo was presented at the 14th International Conference on Thalassaemia & Haemoglobinopathies and 16th TIF International Conference for Patients & Parents
From November 17th to 19th, 2017, the 14th International Conference on Thalassaemia & Haemoglobinopathies and the 16th TIF International Conference for Patients & Parents took place in Thessaloniki, Greece. In this occasion, the poster of the DEEP (DEferiprone Evaluation in Paediatrics) project discussing the DEEP-2 study informative […]
DEEP supports the Rare Disease Day 2018
DEEP project is glad to support The Rare Disease Day 2018, that will take place on the last day of February 28th, to raise awareness of rare diseases and their impact on patients’ lives amongst the general public and decision-makers. The Rare Disease Day was first launched […]